“Put it in the water!” — How a Toxic Tree May Save Thousands of Smokers

Hunterbrook Capital is long $ACHV. Achieve Life Sciences is seeking FDA approval for cytisinicline, a promising smoking cessation therapy. The drug has shown to be safer and more effective than existing treatments and is already used in Europe. With a large addressable market and potential for both anti-smoking and anti-vaping indications, Achieve is well-positioned for growth, although it will need to raise more capital for commercialization.